Cystatin C as a biomarker for cardiorenal syndrome diseases quantitative diagnostics and monitoring via point-of-care. - Xushuo Zhang; Sam Jeffery Fishlock; Peter Sharpe; James McLaughlin 001 (EMBC, 2022)